Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy

Detalles Bibliográficos
Autores principales: Valvo, Victoria, Vitale, Emanuele, Tigano, Marco, Evans, Rachel, Morgan, Meredith A., Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408123/
https://www.ncbi.nlm.nih.gov/pubmed/37560464
http://dx.doi.org/10.3389/fonc.2023.1257622
_version_ 1785086117377212416
author Valvo, Victoria
Vitale, Emanuele
Tigano, Marco
Evans, Rachel
Morgan, Meredith A.
Zhang, Qiang
author_facet Valvo, Victoria
Vitale, Emanuele
Tigano, Marco
Evans, Rachel
Morgan, Meredith A.
Zhang, Qiang
author_sort Valvo, Victoria
collection PubMed
description
format Online
Article
Text
id pubmed-10408123
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104081232023-08-09 Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy Valvo, Victoria Vitale, Emanuele Tigano, Marco Evans, Rachel Morgan, Meredith A. Zhang, Qiang Front Oncol Oncology Frontiers Media S.A. 2023-07-25 /pmc/articles/PMC10408123/ /pubmed/37560464 http://dx.doi.org/10.3389/fonc.2023.1257622 Text en Copyright © 2023 Valvo, Vitale, Tigano, Evans, Morgan and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Valvo, Victoria
Vitale, Emanuele
Tigano, Marco
Evans, Rachel
Morgan, Meredith A.
Zhang, Qiang
Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
title Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
title_full Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
title_fullStr Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
title_full_unstemmed Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
title_short Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
title_sort editorial: targeting dna damage response to enhance antitumor innate immunity in radiotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408123/
https://www.ncbi.nlm.nih.gov/pubmed/37560464
http://dx.doi.org/10.3389/fonc.2023.1257622
work_keys_str_mv AT valvovictoria editorialtargetingdnadamageresponsetoenhanceantitumorinnateimmunityinradiotherapy
AT vitaleemanuele editorialtargetingdnadamageresponsetoenhanceantitumorinnateimmunityinradiotherapy
AT tiganomarco editorialtargetingdnadamageresponsetoenhanceantitumorinnateimmunityinradiotherapy
AT evansrachel editorialtargetingdnadamageresponsetoenhanceantitumorinnateimmunityinradiotherapy
AT morganmereditha editorialtargetingdnadamageresponsetoenhanceantitumorinnateimmunityinradiotherapy
AT zhangqiang editorialtargetingdnadamageresponsetoenhanceantitumorinnateimmunityinradiotherapy

Ejemplares similares